Showing 1 - 20 results of 25 for search 'Jean‐Baptiste Bachet', query time: 0.23s Refine Results
  1. 1
    Treatment of Pancreatic Cancer: What Can We Really Predict Today?
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Is EUS-guided drainage a suitable alternative technique in case of proximal biliary obstruction?
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples.
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Practical considerations in the use of regorafenib in metastatic colorectal cancer
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial)
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Correction: STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial
    Get full text
    Article
    Save to List
    Saved in:
Search Tools: RSS Feed – Email Search